- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 4, 2026 | 46.83M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 48.54M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 48.65M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 48.67M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 48.74M sh |
| Stock Repurchased | Q3 2026 · Mar 31, 2026 | $3.49M |
| Stock Repurchased | Q3 2026 · Mar 31, 2025 | $708K |
| Capex | Q3 2026 · Mar 31, 2026 | $3.45M |
| Capex | Q3 2026 · Mar 31, 2025 | $4.23M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | $29.43M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | $10.15M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $39.69M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $22.94M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $234.34M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $226.02M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $119.07M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $115.15M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $195.55M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $200.69M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $189.26M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $179.25M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $431.21M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $426.77M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.10 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.23 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | $0.05 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | $0.25 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.10 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.24 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $0.05 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $0.26 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $9.25M |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $30.94M |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $9.95M |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $32.27M |
| Net Income | Q3 2026 · Mar 31, 2026 | $4.67M |
| Net Income | Q3 2026 · Mar 31, 2026 | $11.27M |
| Net Income | Q3 2026 · Mar 31, 2025 | $2.54M |
| Net Income | Q3 2026 · Mar 31, 2025 | $12.38M |
| Operating Income | Q3 2026 · Mar 31, 2026 | $6.55M |
| Operating Income | Q3 2026 · Mar 31, 2026 | $16.11M |
| Operating Income | Q3 2026 · Mar 31, 2025 | $3.33M |
| Operating Income | Q3 2026 · Mar 31, 2025 | $15.86M |
| Revenue | Q3 2026 · Mar 31, 2026 | $214.14M |
| Revenue | Q3 2026 · Mar 31, 2026 | $672.92M |
| Revenue | Q3 2026 · Mar 31, 2025 | $214.01M |
| Revenue | Q3 2026 · Mar 31, 2025 | $682.12M |